Is UiPath’s (PATH) Agentic Pivot Reframing Its Automation Moat Or Just Its Marketing Story?

• In late March 2026, UiPath held a special call highlighting its latest agentic business orchestration capabilities and real-world customer outcomes, underscoring its shift from traditional robotic process automation toward a broader AI-powered automation platform.
• At the same time, its award-nominated communications campaign and new agentic purchase-to-pay solution are helping reposition UiPath as an enterprise automation leader even as sales growth and billings trends have been relatively subdued.
• Next, we’ll examine how UiPath’s push into agentic automation, including its new purchase-to-pay solution, may influence the existing investment narrative.

We've uncovered the 11 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

UiPath Investment Narrative Recap

To own UiPath today, you need to believe its shift from classic robotic process automation to a broader agentic AI platform can deepen customer usage and eventually reaccelerate growth, despite recent sluggish sales and billings. The latest special call and product news highlight clear progress on that platform vision, but they do not materially change the near term risk that weaker demand and FX headwinds could weigh on revenue against relatively tight fiscal 2027 guidance.

Among the recent announcements, the new agentic purchase to pay solution is especially relevant. It showcases how UiPath is trying to move higher in the value chain by orchestrating complex, cross system workflows in procurement and accounts payable. If customers adopt this type of solution at scale, it could reinforce the agentic automation catalyst and help counterbalance pressures from the SaaS transition and slower deal closures in more cautious end markets.

Yet beneath the headline momentum in agentic automation, investors should be aware that slower ARR growth and subdued billings trends could still...

Read the full narrative on UiPath (it's free!)

UiPath's narrative projects $2.1 billion revenue and $147.2 million earnings by 2029.

Uncover how UiPath's forecasts yield a $13.80 fair value, a 39% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were looking for about 9.4% annual revenue growth to roughly US$2.1 billion by 2029, yet the same bullish view highlights how dependence on large, long cycle projects in regulated sectors could still stall higher value AI ARR if sales slow, reminding you that even positive takes on the recent agentic announcements can differ widely and may shift as new information comes in.

Explore 11 other fair value estimates on UiPath - why the stock might be worth just $13.80!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your UiPath research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free UiPath research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate UiPath's overall financial health at a glance.

Interested In Other Possibilities?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 32 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com